Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Perrigo Company plc    PRGO   IE00BGH1M568

PERRIGO COMPANY PLC

(PRGO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • Technically, the stock approaches a strong medium-term resistance at USD 60.8.
  • The company is in debt and has limited leeway for investment
  • The company's earnings releases usually do not meet expectations.
Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
PERRIGO COMPANY PLC6.70%7 514
JOHNSON & JOHNSON0.93%387 604
ROCHE HOLDING AG2.26%299 665
PFIZER, INC.-2.02%213 250
MERCK & CO., INC.-10.20%206 143
NOVARTIS AG-16.12%185 541
ABBVIE INC.6.49%166 171
NOVO NORDISK A/S6.10%151 044
ASTRAZENECA PLC12.40%146 534
AMGEN INC.1.05%142 669
ELI LILLY AND COMPANY17.82%140 367
BRISTOL-MYERS SQUIBB COMPAN..-7.35%134 562
SANOFI-1.57%130 441
GLAXOSMITHKLINE PLC-11.58%102 242
CHUGAI PHARMACEUTICAL CO., ..46.61%76 269
JIANGSU HENGRUI MEDICINE CO..27.23%71 217
More Results
Financials (USD)
Sales 2020 5 179 M - -
Net income 2020 268 M - -
Net Debt 2020 2 700 M - -
P/E ratio 2020 24,5x
Yield 2020 1,75%
Capitalization 7 514 M 7 514 M -
EV / Sales 2020 1,97x
EV / Sales 2021 1,86x
Nbr of Employees 11 200
Free-Float 99,4%
Upcoming event on PERRIGO COMPANY PLC
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability -
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield
Consensus
7 days EPS revision -
4 months EPS revision -
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes